Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

Patient demographics and baseline characteristics for patients with T1N0 hormone receptor–positive breast cancer from the Stockholm randomized trial and multi-institutional cohort